Roupen Odabashian, Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared a post on LinkedIn:
“The last 3 years at Karmanos Cancer Institute were some of the best years of my training!
I was able to be part of history, treating patients with Daraxonrasib, the new treatment for pancreatic cancer.
I was able to see patients on the most advanced treatments and Phase 1 and Phase 2 trials.
I took care of many patients, and many physicians took care of me, teaching me how to become a good researcher and clinician.
I am very excited for the next chapter of my life on the West Coast!
Next, we are heading to BC, Canada, and I can’t wait to start my course in ML at Stanford University. Second degree here I come!”
Other articles featuring Roupen Odabashian on Oncodaily.